36.9 F
New York
Friday, January 22, 2021

Sanofi [NASDAQ: SNY] And GlaxoSmithKline [NYSE: GSK] Plans To Close $500 Million UK COVID-19 Vaccine Deal

Must read

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Thermo fisher scientific inc revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price...

Shutterstock [NYSE: SSTK] To Extend Its Agreement With EPA

Shutterstock reported that the company renewed its exclusive contract with the European Pressphoto Agency. The extended contract is to distribute the visual content...

Sanofi [NASDAQ: SNY], a French pharmaceutical company and GlaxoSmithKline [NYSE: GSK], a British pharmaceutical company agreed to close a $500 million deal with Britain. According to the deal, Sanofi and GSK will supply 60 million doses of their coronavirus vaccine to the UK.

Sourced disclosed that the UK was considering an option to buy the vaccine if it worked on human trials, which are set to begin in September. Sanofi is at the forefront of the fight against COVID-19. Sanofi announced its collaboration with BARDA for the development of the coronavirus vaccine on February 18.

In early March, SNY starts a discussion with GSK for the coronavirus vaccine. On April 14, it declared that it has partnered with GSK for a baculovirus candidate. On June 23, it has announced the accelerated program for baculovirus vaccine candidate, with the potential launch by H1 2021 with up to 1 billion doses.

Shares of SNY soared 0.68% at $51.62 during the last trading session of Thursday. It has a day low and day high range of 51.32-51.79, respectively. SNY had a trading volume of roughly 720.19k as compared to the average volume of 1.94 million.

In the past 52-weeks of trading, SNY stocks have oscillated between a low of $37.62 and a peak of $52.94. This firm’s Gross Margin is currently 68.00%, and Operating Margin is 16.20%, and the profit margin is 13.60%.

GlaxoSmithKline also closely monitors the coronavirus Pandemic and striving to help the world with their science and expertise. GSK aimed to develop multiple adjuvanted COVID-19 vaccines. GSK plans to produce 1 billion coronavirus vaccine doses in 2021.

At the most recent market close, GSK shares were valued at $41.22. It has a total market capitalization of 101.86 billion. GSK shares were up 0.88% during the last trading session on Thursday.

It has moved down -14.57% from its 52-weeks high and moved up 31.15% from its 52-weeks low. GSK’s gross margin is 68.20%, the operating margin is 21.50%, and the profit margin is 15.30%. This company’s return on assets (ROA) is 6.90%, return on equity (ROE) is 54.00%, and return on investment (ROI) is 14.30%.

More articles

Latest article

Tencent Music [NYSE: TME] To Purchase 100% Equity Interest Of Lazy Audio

Tencent Music Entertainment Group reported that the company has signed a contract to purchase 100 percent shares of Lazy Audio. Lazy audio is...

Desktop Metal [NYSE: DM] Inks Agreement To Purchase EnvisionTEC

Desktop Metal reported that the company inked a definitive contract to purchase EnvisionTEC. Desktop Metal will purchase EnvisionTEC for a total consideration of...

Sequential Brands [NASDAQ: SQBG] Partnered With Omega Apparel To Create A New Collection

Sequential Brands Group reported that the company has collaborated with Omega Apparel for its denim business. With this partnership, the company will develop...

Marathon Petroleum [NYSE: MPC] Appoints New CFO

Marathon Petroleum Corp. reported that the company has named Maryann T. Mannen as the CFO and Executive V.P of the company. Maryann has...

QUALCOMM [NASDAQ: QCOM] Announces To Purchase NUVIA For $1.4Billion

QUALCOMM Incorporated reported that its unit, Qualcomm technologies inked a contract to purchase NUVIA.  The company will purchase NUVIA for nearly $1.4B. The...

Trivago [NASDAQ: TRVG] Reported The Purchase Of Weekend.com

Trivago reported that the company has purchased Weekend.com. Weekend it just started based in Germany, its main aim is to provide stimulating getaway...

Arthur J. Gallagher [NYSE: AJG] Reports To Purchase 100% of The Bollington Wilson Group

Arthur J. Gallagher reported that the company has inked a contract to buy 100% of the Bollington Wilson group. Bollington is an insurance...

Grainger [NYSE: GWW] Reports Changes In The Executive Leadership

Grainger reported changes in its Executive leadership. The leading supplier and distributor of MRO products appointed Deidra Merriwether as the Chief Financial officer....